Roundtable on Genomics and Precision Health
The Roundtable on Genomics and Precision Health brings together voices in the field to encourage innovation and actions that foster the wide adoption of and access to the benefits of genomics and precision health. Our vision is to realize the full potential of health for all through genomics and precision health. Our current work focuses on driving innovation, spurring adoption, driving access, and shaping the policy dialogue about genomics and precision health.
In progress
Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date.
"We catalyze innovation and actions that foster the wide adoption of and access to genomics and precision health."
Innovative approaches can accelerate the commercialization and integration of genomics-based diagnostics, tools, and therapies. The roundtable explores barriers and facilitators of innovation, lessons learned from successful innovation efforts, and ways to ensure new technologies for participants and patients.
Past Work:
• Exploring Applications of AI in Genomics and Precision Health: A Workshop
• Direct to Consumer Genetic Testing: What are the Policy Issues that Society Must Address? A Workshop
• Innovations in Service Delivery in the Age of Genomics: A Workshop
• Diffusion and Use of Genomic Innovations in Health and Medicine: A Workshop
• DIGITizE: Displaying and Integrating Genetic Information Through the EHR Action Collaborative
• Establishing Precompetitive Collaborations to Stimulate Genomics Driven Drug Development: A Workshop
• Barriers to the Development and Utilization of Genome-Based Diagnostic Technologies: A Workshop
• The Role of Digital Health Technologies in Drug Development: A Workshop
• Exploring the Current Landscape of Consumer Genomics: A Workshop
• Sharing Clinical Trial Data: Reflecting Back and Looking Ahead - A Workshop
• Deriving Drug Discovery Value from Large-Scale Genetic Bioresources: A Workshop
• Genomics-Enabled Drug Repurposing and Repositioning: A Workshop
• Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development: A Workshop
Through a variety of activities, collaborations, and engaging new voices, the roundtable shares their work and outputs to inform and advance the field of genomics and precision health.
Past Work:
• The Value of Genetic and Genomic Technologies: A Workshop
• Event - Views & Voices: Reporting Genetics and Genomics
• Event- Strategic Plan Reflection on the Roundtable's Work since 2020
• National Society of Genetic Counselors Webinar: Realizing the Full Potential of Health for All Through Genomics and Precision Health - A discussion with the National Academies Genomics Roundtable.
• Genetically Speaking Mini-Series: The Future of Genomics and Precision Health - Roundtable members were invited to participate in this external activity.
*Disclaimer: This article is not produced by the National Academies of Sciences, Engineering, and Medicine and may not represent the views of the institution.
Despite advances in genomics, integrating genomics data in clinical care has been challenging. The roundtable highlights evidence-based practices across health care and public health for bridging the gap from genomics research to the implementation of and access to genomics and precision health in clinical care.
Past Work:
• Examining Clinical Guidelines for the Adoption of Genomics Testing: A Workshop
• Sustaining Community Engagement in Genomics Research: A Workshop
• Improving Diversity of the Genomics Workforce: A Workshop
• Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: A Workshop
• Evidence Generation for Genomic Diagnostic Test Development: A Workshop
• Genomics and Population Health Action Collaborative
• Applying an Implementation Science Approach to Genomic Medicine: A Workshop
• Improving Genetics Education in Graduate and Continuing Health Professional Education: A Workshop
• Assessing Genomic Sequencing Information for Health Care Decision Making: A Workshop
• Improving the Efficiency and Effectiveness of Genomic Science Translation: A Workshop
• Evidence for Clinical Utility of Molecular Diagnostics in Oncology: A Workshop
• Assessing the Economics of Genomic Medicine: A Workshop
• Implementing and Evaluating Genomic Screening Programs in Health Care Systems: A Workshop
• Understanding Disparities in Access to Genomic Medicine: A Workshop
• Improving racial diversity in the genomics workforce: An examination of challenges and opportunities*
*Disclaimer: This article is not produced by the National Academies of Sciences, Engineering, and Medicine and may not represent the views of the institution.
Our mission
The work of this roundtable engages a variety of interested parties to encourage innovation, spur adoption and implementation, and shape dialogue in genomics and precision health. Roundtable activities, including public workshops, membership meetings, Action Collaboratives, and other information-gathering activities, provide opportunities for discussing pressing challenges and developments in the field to highlight potential solutions, encourage collaboration, and identify areas for action.
The roundtable membership includes leaders from government, academia, pharmaceutical and biotechnology companies, professional groups and associations, health systems, and patient-focused organizations. Roundtable members work together to illuminate critical issues in the field and explore opportunities for driving innovation, spurring adoption and access, and shaping the policy dialogue on genomics and precision health. View members.
Roundtables create communal environments to foster dialogue across sectors and institutions. Although roundtables do not produce solutions themselves, they illuminate issues that need to be resolved, and opportunities for further work are often developed from meetings, workshops, and publications. For example, the activities of a roundtable may result in the establishment of a separate consensus study committee. Unlike a consensus study committee, which publishes a report with conclusions and recommendations, a roundtable may not issue work with such advice.
The roundtable brings together leaders from government, academia, industry, foundations, associations, patient communities, and health systems, and in doing so serves to drive innovation, spur adoption and access, and shape the policy dialogue on genomics and precision health.
Contact Sarah Beachy:
Description
The Roundtable on Genomics and Precision Health (previously called the Roundtable on Translating Genomic-Based Research for Health) brings together leaders from government, academia, industry, foundations, associations, patient communities, and other stakeholder groups to meet and discuss global issues surrounding the translation of genomics and genetics research findings into medicine, public health, education, and policy. The primary purpose of the Roundtable is to foster dialogue across sectors and among interested parties and institutions, and to illuminate and scrutinize critical scientific and policy issues where Roundtable engagement and input will help further the field.
The Roundtable membership identifies scientific and policy issues where discussion and collaboration will help enable the translation of genomics into health care applications. Specific issues and agenda topics are determined by the Roundtable members, and span a broad range of issues relevant to the translation process. Current areas of emphasis include the development of targeted therapeutics and diagnostics, clinical implementation of genomic medicine, health IT and mhealth, the use of genomic information for health care decision making, next generation sequencing, using genomic information and data science to generate knowledge for clinical practice and research, and education and ethical, legal, and social issues.
To achieve its objectives, the Roundtable conducts structured discussions, public workshops, and symposia and enters into information-gathering activities, develops authored perspectives, organizes collaboratives, and publishes workshop summaries.
Collaborators
Committee
Robert L. Nussbaum
Co-Chair
Catherine A. Wicklund
Co-Chair
Devin Absher
Ex Officio Member
Aris Baras
Ex Officio Member
James Beck
Ex Officio Member
Natasha Bonhomme
Ex Officio Member
Colleen Caleshu
Ex Officio Member
Christina Daulton
Ex Officio Member
Aaron Goldenberg
Ex Officio Member
Jennifer Goldsack
Ex Officio Member
Richard J. Hodes
Ex Officio Member
Adriana Huertas-Vazquez
Ex Officio Member
Jessica Hurt
Ex Officio Member
Mira Irons
Ex Officio Member
Jennie Jarrett
Ex Officio Member
Katherine Johansen Taber
Ex Officio Member
Sarah Kalia
Ex Officio Member
Alisha S. Keehn
Ex Officio Member
Muin J. Khoury
Ex Officio Member
Bruce Korf
Ex Officio Member
Charles Lee
Ex Officio Member
Debra G. Leonard
Ex Officio Member
Toby Lowe
Ex Officio Member
Christa Martin
Ex Officio Member
Jennifer Moser
Ex Officio Member
Kenneth Offit
Ex Officio Member
Amanda Perl
Ex Officio Member
Jonathan Pevsner
Ex Officio Member
Kathryn A. Phillips
Ex Officio Member
Victoria M. Pratt
Ex Officio Member
Sheri Schully
Ex Officio Member
Anil Shanker
Ex Officio Member
Angela Starkweather
Ex Officio Member
Sharon Terry
Ex Officio Member
Joyce Tung
Ex Officio Member
Karen Weck
Ex Officio Member
Michelle Ann Penny
Member
Jacquelyn Y. Taylor
Member
Sarah Wordsworth
Member
Sponsors
23andMe
All of Us Research Program
American Academy of Nursing
American College of Medical Genetics and Genomics
American Medical Association
American Society of Clinical Oncology
American Society of Human Genetics
Association for Molecular Pathology
Biogen
College of American Pathologists
Geisinger Health
Genome Medical
Health Resources and Services Administration
Illumina Inc.
Kaiser Permanente
Myriad Genetics
National Cancer Institute
National Human Genome Research Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute on Aging
National Society of Genetic Counselors, Inc
The Jackson Laboratory (JAX)
University of California, San Francisco
University of Vermont Health Network Medical Group
Staff
Sarah Beachy
Lead
Michelle Drewry
Ashley Pitt
Major units and sub-units
Center for Health, People, and Places
Lead
Biomedical and Health Sciences Program Area
Lead